- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05838651
Socket Preservation With BioHorizon's Striate+ Membrane and MinerOss X Plug
The Combination of BioHorizon's Striate+ Membrane in Conjunction With MinerOss X Plug for Providing Hard Tissue Regeneration in Socket Preservation Procedure
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this proposed clinical trial is to provide detailed comparison and evidence of new bone formation in patients undergoing socket preservation utilizing two widely accepted treatment modalities that are used to maintain ridge dimension after a tooth extraction.
The specific aims of the study are:
- To demonstrate the efficacy of a Striate+ membrane in conjunction with a bone graft substitute for providing hard tissue regeneration in the socket preservation procedure.
- To determine the safety of Striate+ membrane when primary flap closure over the membrane is not achieved in the socket preservation procedure.
- To provide detailed evidence of new bone formation in patients undergoing socket preservation procedures by means of clinical, radiographic, histologic, and histomorphometric analyses.
It is currently unclear if one treatment is more effective than the other. The two treatments being compared are:
Treatment 1: Socket preservation sites with bone graft (MinerOss® X Plug) alone without complete flap closure (secondary intention healing) (n=10) Treatment 2: Socket preservation sites with bone graft (MinerOss® X Plug) and a non-crosslinked collagen membrane without complete flap closure (secondary intention healing) (n=10)
MinerOss® X Plug: A xenograft composed of 80% bovine cancellous particulate and 20% bovine Type I collagen. The 20% collagen prevents particulate migration.
Striate+ Membrane: A non-crosslinked collagen covering used to keep bacteria out and hold the bone graft in place.
Secondary intention healing (without complete flap closure): The wound edges are not brought together (i.e. knee scrape).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chia-Yu Chen, DDS, DMSc
- Phone Number: 857-576-0279
- Email: chia-yu_chen@hsdm.harvard.edu
Study Contact Backup
- Name: David M Kim, DDS, DMSc
- Phone Number: 617-432-1472
- Email: dkim@hsdm.harvard.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female, between 20-70 years of age, who requests dental implant treatment option for rehabilitation.
- Subjects who are willing to sign an informed consent, participate and return for follow-up visits.
- Subjects without significant medical history and currently not on medications that might complicate our results.
- Has a single-rooted tooth (upper and lower premolars to premolars) requiring extraction with two neighboring teeth on either side of it and intact bony walls.
Exclusion Criteria:
- Subjects who do not meet all the inclusion criteria or who will not cooperate with the protocol schedule.
- Subjects who received and failed a previously placed dental implant.
- Subjects who require additional ridge augmentation procedure in the area to achieve adequate bone volume for the placement of dental implants.
- Subjects who have significant untreated periodontal disease, caries, infection or chronic inflammation in the oral cavity within two adjacent tooth positions of the clinical trial area.
- Subjects who have used nicotine-containing products within 3 weeks prior to surgery.
- Subjects who are insulin-dependent diabetic or if their Hgb1c levels > 6.5%.
- Subjects who have had a history of malignancy within the past 5 years (except for basal or squamous cell carcinoma of the skin or in situ cervical carcinoma).
- Subjects who are nursing or pregnant.
- Subjects who are presently taking medications (except estrogen/progesterone therapy) or those who are undergoing treatment that in known to have an effect on bone turnover.
- Subjects who have diseases that affect bone metabolism (excluding idiopathic osteoporosis).
- Subjects with a history of an autoimmune disease, documented allergy or multiple allergies to any component of the agents used in this study.
- Difficult extraction with potential disruption / fracture of the alveolar bone.
- Acutely infected defect site.
- Subjects who are presently taking blood thinner medications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Bone Graft Alone
Socket preservation sites with bone graft (MinerOss® X Plug) alone without complete flap closure (secondary intention healing) (n=10)
|
A xenograft composed of 80% bovine cancellous particulate and 20% bovine Type I collagen.
|
Experimental: Bone Graft + Membrane
Socket preservation sites with bone graft (MinerOss® X Plug) and a non-crosslinked collagen membrane without complete flap closure (secondary intention healing) (n=10)
|
A xenograft composed of 80% bovine cancellous particulate and 20% bovine Type I collagen.
A non-crosslinked collagen covering used to keep bacteria out and hold the bone graft in place.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
radiographic ridge width
Time Frame: 12 months
|
To provide detailed evidence of new bone formation in patients undergoing socket preservation procedures.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
gingival thickness
Time Frame: 12 months
|
To assess soft tissue changes.
|
12 months
|
radiographic alveolar height
Time Frame: 12 months
|
To assess radiographic hard tissue changes.
|
12 months
|
clinical alveolar height and width
Time Frame: 12 months
|
To assess clinical hard tissue changes.
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: David M Kim, DDS, DMSc, Harvard School of Dental Medicine
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB23-0179
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Socket Preservation
-
Cairo UniversityRecruiting
-
Cairo UniversityRecruiting
-
Cairo UniversityCompleted
-
Cairo UniversityUnknown
-
Mansoura UniversityActive, not recruiting
-
SVS Institute of Dental SciencesUnknown
-
Nahed Gamal Saleh AbdelaalUnknown
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
Ain Shams UniversityCompletedSocket PreservationEgypt
Clinical Trials on MinerOss® X Plug
-
University of TennesseeCompleted
-
Tufts UniversityCompletedTooth Extraction Status Nos
-
W.L.Gore & AssociatesTerminated
-
Mati Therapeutics Inc.CompletedDry Eye SyndromesUnited States
-
Tufts UniversityCompletedLoss of Teeth Due to ExtractionUnited States
-
Cook Group IncorporatedCompletedAnorectal FistulaUnited States, Germany
-
University Hospital, Basel, SwitzerlandUnity Health Toronto; Mount Sinai Hospital, Canada; Women's College Hospital; St...CompletedComplex Anal FistulaSwitzerland
-
Medtronic Spine LLCWithdrawnLumbar Spinal Stenosis
-
Cairo UniversityUnknown